Qisda announced an 18% cash capital reduction to optimize its capital structure and enhance shareholder returns, completing the issuance of new shares and resuming trading on the 7th. In recent years, the company has strategically focused on high-value businesses such as medical imaging, networking, and AIoT, while actively pursuing mergers and acquisitions to expand its footprint in Europe.

The company reported growth across its three main business segments—smart solutions, medical, and networking—in the first three quarters of 2025 compared with the same period last year. Qisda also noted that the fourth quarter carries uncertainties, including potential cost increases for end products due to U.S. policy investigations, inflationary pressures, and the impact of employment data on consumer demand, all of which require ongoing monitoring.

Qisda is actively seeking acquisition targets in Europe, with a focus on profitable companies.

Resource: 佳世達辦理減資完成；續併購擴張歐洲布局